Login
Toggle sidebar

Lint: assessment-of-thyroid-lesions-general

assessment-of-thyroid-lesions-general
Acronyms
warning

"SCC: rare"

Line 26:8 · 'SCC' has no definition. Spell it out if it's unfamiliar to the audience.

"Indications for FNA"

Line 68:21 · 'FNA' has no definition. Spell it out if it's unfamiliar to the audience.

"Each grading system provides recommendations for when FNA is indicated (see snippet for individual systems)."

Line 69:58 · 'FNA' has no definition. Spell it out if it's unfamiliar to the audience.

"The criteria developed by the American Thyroid Association (2015) 6 are often used in clinical practice. See ATA guidelines for assessment of thyroid nodules."

Line 71:144 · 'ATA' has no definition. Spell it out if it's unfamiliar to the audience.

"The ACR TI-RADS system recommends FNA for TR3 lesions >25 mm, TR4 lesions >15 mm and TR5 lesions >10 mm 11."

Line 72:11 · 'ACR' has no definition. Spell it out if it's unfamiliar to the audience.

"The ACR TI-RADS system recommends FNA for TR3 lesions >25 mm, TR4 lesions >15 mm and TR5 lesions >10 mm 11."

Line 72:15 · 'TI-RADS' has no definition. Spell it out if it's unfamiliar to the audience.

"The ACR TI-RADS system recommends FNA for TR3 lesions >25 mm, TR4 lesions >15 mm and TR5 lesions >10 mm 11."

Line 72:45 · 'FNA' has no definition. Spell it out if it's unfamiliar to the audience.

"The BTA U classification recommends FNA for any non-benign lesion (i.e. U3, U4 or U5) 12."

Line 73:11 · 'BTA' has no definition. Spell it out if it's unfamiliar to the audience.

"The BTA U classification recommends FNA for any non-benign lesion (i.e. U3, U4 or U5) 12."

Line 73:47 · 'FNA' has no definition. Spell it out if it's unfamiliar to the audience.

"Additional recommendations for FNA by the American Association of Clinical Endocrinologists 4:"

Line 74:35 · 'FNA' has no definition. Spell it out if it's unfamiliar to the audience.

"FNA recommended for nodules"

Line 75:12 · 'FNA' has no definition. Spell it out if it's unfamiliar to the audience.

"Management of FNA results"

Line 76:19 · 'FNA' has no definition. Spell it out if it's unfamiliar to the audience.

"atypia of uncertain significance / follicular lesion of uncertain significance (AUS/FLUS)"

Line 92:84 · 'AUS' has no definition. Spell it out if it's unfamiliar to the audience.

"atypia of uncertain significance / follicular lesion of uncertain significance (AUS/FLUS)"

Line 92:88 · 'FLUS' has no definition. Spell it out if it's unfamiliar to the audience.

"3-6% of all FNA"

Line 94:20 · 'FNA' has no definition. Spell it out if it's unfamiliar to the audience.

"repeat FNA"

Line 96:11 · 'FNA' has no definition. Spell it out if it's unfamiliar to the audience.

"if AUS/FLUS again (~20%) on the first sample, then the risk of malignancy is 5-15% 10"

Line 99:11 · 'AUS' has no definition. Spell it out if it's unfamiliar to the audience.

"if AUS/FLUS again (~20%) on the first sample, then the risk of malignancy is 5-15% 10"

Line 99:15 · 'FLUS' has no definition. Spell it out if it's unfamiliar to the audience.
Colons
warning

"Thyroid enlargement: The patients complain of a visible swelling in the neck, a heavy feeling and discomfort when swallowing, or difficulty with respiration. They sometimes awake with a start for shortness of breath just after having fallen asleep. Occasionally they may complain about vague, irritating pain."

Line 50:23 · The first word after a colon should almost always be lowercase. In this case, it's not: ': The patients'.
Strong
warning

"The mass may be diffusely enlarged with hyperthyroidism (Graves / thyroiditis) or normal function (colloid, goitre or iodine deficiency). The mass may show multinodularity with hyperfunction of secondary hyperthyroidism or mutinodularity with normal function of multinodular hyperplasia."

Line 52:4 · Generally, don't use bold in text: 'The mass may be diffusely enlarged with hyperthyroidism (Graves / thyroiditis) or normal function (colloid, goitre or iodine deficiency). The mass may show<strong> </strong>multinodularity'

"The mass may be diffusely enlarged with hyperthyroidism (Graves / thyroiditis) or normal function (colloid, goitre or iodine deficiency). The mass may show multinodularity with hyperfunction of secondary hyperthyroidism or mutinodularity with normal function of multinodular hyperplasia."

Line 52:177 · Generally, don't use bold in text: 'multinodularity<strong> </strong>with hyperfunction of secondary hyperthyroidism or mutinodularity with normal function of multinodular hyperplasia'

"The criteria developed by the American Thyroid Association (2015) 6 are often used in clinical practice. See ATA guidelines for assessment of thyroid nodules."

Line 71:34 · Generally, don't use bold in text: '<strong>American Thyroid Association</strong>'
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Thyroid mass"

Line 2:1 · "Thyroid mass" is not a recognised heading for this article type.

"Risk factors for malignancy"

Line 40:1 · "Risk factors for malignancy" is not a recognised heading for this article type.

"Indications for FNA"

Line 68:1 · "Indications for FNA" is not a recognised heading for this article type.

"Management of FNA results"

Line 76:1 · "Management of FNA results" is not a recognised heading for this article type.

"Staging"

Line 113:1 · "Staging" is not a recognised heading for this article type.
Oxford Comma
suggestion

"The mass may be diffusely enlarged with hyperthyroidism (Graves / thyroiditis) or normal function (colloid, goitre or iodine deficiency). The mass may show multinodularity with hyperfunction of secondary hyperthyroidism or mutinodularity with normal function of multinodular hyperplasia."

Line 52:103 · Use the Oxford comma in 'colloid, goitre or iodine'.

"There maybe a single autonomically hyperfunctioning adenoma or a single nodule with 'relatively normal function' of an adenoma, cyst or carcinoma."

Line 53:123 · Use the Oxford comma in 'adenoma, cyst or carcinoma'.

"The BTA U classification recommends FNA for any non-benign lesion (i.e. U3, U4 or U5) 12."

Line 73:83 · Use the Oxford comma in 'U3, U4 or U5'.
Links
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0